(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Castle Biosciences, Celsius Holdings, and Novavax.

Rank Financial Asset Price Change Updated (EST)
1 Castle Biosciences (CSTL) 22.11 23.33% 2022-06-23 14:48:33
2 Celsius Holdings (CELH) 63.86 14.71% 2022-06-23 14:48:23
3 Novavax (NVAX) 51.78 13.86% 2022-06-23 14:58:32
4 Niu Technologies (NIU) 8.75 13.78% 2022-06-23 14:49:53
5 Coinbase (COIN) 58.92 13.5% 2022-06-23 14:54:02
6 Wayfair (W) 54.13 12.78% 2022-06-23 14:52:07
7 Pacific Biosciences of California (PACB) 5.46 12.11% 2022-06-23 14:58:46
8 Aspen Group (ASPU) 0.96 11.63% 2022-06-23 14:47:57
9 Accuray Incorporated (ARAY) 2.14 11.46% 2022-06-23 15:08:06
10 10x Genomics (TXG) 46.49 11.45% 2022-06-23 14:51:05

The three most active and biggest losers today are Acorda Therapeutics, Advaxis, and Deutsche Bank.

Rank Financial Asset Price Change Updated (EST)
1 Acorda Therapeutics (ACOR) 0.52 -15.32% 2022-06-23 07:09:50
2 Advaxis (ADXS) 0.06 -13.77% 2022-06-23 07:49:15
3 Deutsche Bank (DB) 9.06 -11.4% 2022-06-23 14:54:10
4 W&T Offshore (WTI) 4.96 -10.47% 2022-06-23 04:09:50
5 Vermilion Energy (VET) 18.57 -8.97% 2022-06-22 23:09:06
6 AGCO (AGCO) 97.13 -8.53% 2022-06-23 14:55:54
7 Antero Resources (AR) 30.55 -8.53% 2022-06-23 14:56:16
8 Cenovus Energy (CVE) 17.77 -8.42% 2022-06-23 14:58:37
9 CNH Industrial (CNHI) 11.40 -8.39% 2022-06-23 14:53:48
10 Valero Energy (VLO) 104.50 -7.63% 2022-06-23 14:59:21

Most Active Winners today

1. Castle Biosciences (CSTL) – 23.33%

Castle Biosciences, Inc., which is a company that develops and markets diagnostic and prognostic tools for skin cancers, has reached commercial stage. DecisionDx–Melanoma is the company’s flagship product. This multi-gene expression profil (GEP test) identifies stage I/I patients who are at highest risk for metastasis using biological information taken from 31 tumor tissues. DecisionDx-UM is a GEP proprietary test which predicts metastasis risk for patients suffering from uveal melanoma. There are also two proprietary products at late stage that address cutaneous squamous cells carcinoma and suspicious pigmented lesion, both indications of high clinical need in dermatological. The company offers testing services via physicians, nurse practitioners, and physician assistants. It was established in Texas in 2007.

NASDAQ ended the session with Castle Biosciences rising 23.33% to $22.11 on Thursday while NASDAQ rose 1.62% to $11,232.19.

Volume

Today’s last reported volume for Castle Biosciences is 572811 which is 45.75% above its average volume of 392988.

Castle Biosciences’s last close was $17.93, 77.28% under its 52-week high of $78.92.

The company’s growth estimates for the ongoing quarter and the next is a negative 114.3% and a negative 68.1%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Castle Biosciences’s stock is considered to be oversold (<=20).

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $22.11 at 17:32 EST, way below its 52-week high of $78.92 and way above its 52-week low of $17.01.

Castle Biosciences’s Moving Average

Castle Biosciences’s value is way under its 50-day moving average of $24.61 and way below its 200-day moving average of $44.68.

More news about Castle Biosciences.

2. Celsius Holdings (CELH) – 14.71%

Celsius Holdings, Inc. markets, distributes, sells and promotes functional, calorie-burning, fitness drinks in the United States as well as internationally. It offers a variety of beverages, such as carbonated orange and wild berry, cola and grape, kiwi guava and watermelon. Celsius Heat is a nutritional supplement that contains carbonated flavorings such as orange jack’d and blueberry pomegranate. Blueberry pomegranate. strawberry dragonfruit. tangerine grapefruit. It distributes products via direct-store distribution distributors as well as retailers that include supermarkets and convenience stores as well as drug and nutritional stores and mass merchants. In January 2007, Celsius Holdings, Inc. was established. Celsius Holdings, Inc., was established in 2004. It is located in Boca Raton, Florida.

NASDAQ ended the session with Celsius Holdings rising 14.71% to $63.86 on Thursday, following the last session’s upward trend. NASDAQ rose 1.62% to $11,232.19, following the last session’s downward trend on what was an all-around positive trend trading session today.

Volume

Today’s last reported volume for Celsius Holdings is 1218800 which is 30.3% above its average volume of 935341.

Celsius Holdings’s last close was $55.67, 49.49% below its 52-week high of $110.22.

Celsius Holdings’s Sales

Celsius Holdings’s sales growth is 117.7% for the current quarter and 64.5% for the next. The company’s growth estimates for the present quarter and the next is 20% and 233.3%, respectively.

Celsius Holdings’s Revenue

Year-on-year quarterly revenue growth grew by 192.3%, now sitting on 314.27M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Celsius Holdings’s stock is considered to be oversold (<=20).

Celsius Holdings’s Stock Yearly Top and Bottom Value

Celsius Holdings’s stock is valued at $63.86 at 17:32 EST, way under its 52-week high of $110.22 and way higher than its 52-week low of $38.31.

Celsius Holdings’s Moving Average

Celsius Holdings’s worth is way above its 50-day moving average of $57.21 and below its 200-day moving average of $68.34.

More news about Celsius Holdings.

3. Novavax (NVAX) – 13.86%

Novavax, Inc., along with Novavax AB, a subsidiary, focuses on developing, commercializing and marketing vaccines that prevent serious infections. ResVax is a candidate for a vaccine against respiratory syncytial viruses (RSV), fusion (F), protein nanoparticles. It’s currently in Phase III clinical trials to prevent RSV infection in infants through maternal immunization. NanoFlu is also in Phase III clinical trials and can be used to treat seasonal influenza in elderly adults. Matrix-M is the company’s main adjuvant. It is used to increase the immune system attack against microorganisms and to immunize with lower levels of antigen. RSV F vaccine is being developed by the company for elderly (60+) and healthy children (6 months to 5 years old). Phase II clinical trials are ongoing. Phase I clinical trials are underway for both. It is also developing nanoparticle vaccine candidates to be used in clinic testing for the ebola virus. The company also has a COVID-19 vaccine being developed for the coronavirus, which causes symptoms similar to pneumonia. This is currently in preclinical phase. Novavax, Inc., was established in 1987. It is located in Gaithersburg, Maryland.

NASDAQ ended the session with Novavax rising 13.86% to $51.78 on Thursday while NASDAQ jumped 1.62% to $11,232.19.

Volume

Today’s last reported volume for Novavax is 5914700 which is 0.5% below its average volume of 5944510.

Novavax’s last close was $45.48, 83.63% under its 52-week high of $277.80.

News about Novavax today

  • Novavax stock surges after Covid-19 vaccine recommended for expanded CMA in the EU for 12-17 year olds. According to today’s article on MarketWatch, "Shares of Novavax Inc. shot up 9.8% in afternoon trading Thursday, after the biotechnology company said its COVID-19 vaccine Nuvaxovid has been recommended by the Committee for Medicinal Products for Human Use (CHMP) for expanded conditional marketing authorization (CMA) in the European Union for people aged 12 through 17. ", "This recommendation brings us closer to offering adolescents in the EU the first protein-based COVID-19 vaccine developed using an innovative approach to traditional technology," said Novavax Chief Executive Stanley Erck. "

The company’s growth estimates for the present quarter and the next is 210.7% and 254.1%, respectively.

Novavax’s Revenue

Year-on-year quarterly revenue growth declined by 20.5%, now sitting on 1.15B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novavax’s stock is considered to be oversold (<=20).

Novavax’s Stock Yearly Top and Bottom Value

Novavax’s stock is valued at $51.78 at 17:32 EST, way below its 52-week high of $277.80 and way above its 52-week low of $34.88.

Novavax’s Moving Average

Novavax’s value is above its 50-day moving average of $50.63 and way below its 200-day moving average of $120.50.

More news about Novavax.

4. Niu Technologies (NIU) – 13.78%

Niu Technologies manufactures and sells electric scooters in China. Under the NIU name, Niu Technologies offers e-scooters in NQi (MQi), UQi, Gova, and UQi series; RQi or TQi series electric bikes for urban commuters; NIU Aero professional mountain and road bicycles. The company also offers accessories for scooters such as raincoats. gloves. knee pads. storage baskets. tail boxes. smart phone holders. backrests. locks. Lifestyle accessories include T-shirts. coats. jeans. bags. jewelry. notebook. badges. key chains. mugs. Performance upgrade components consist of shock absorbers. brake calipers. and carbon fiber body panels. The company also offers an app called NIU that allows you to request repairs online, locate a service station, report theft, and provide smart services. NIU Cover, which offers insurance, is available as well. NIU Care offers maintenance and reserve services in off-line service stations. It sells its products and services them through franchised shops, city partners, third-party online platforms and company’s own website. It had 235 partners in cities and 1050 franchised shops in around 180 cities of the People’s Republic of China. There were also 29 international distributors. It was established in Beijing, China in 2014.

NASDAQ ended the session with Niu Technologies rising 13.78% to $8.75 on Thursday, following the last session’s downward trend. NASDAQ jumped 1.62% to $11,232.19, following the last session’s downward trend on what was an all-around bullish trend trading session today.

Volume

Today’s last reported volume for Niu Technologies is 628370 which is 56.38% above its average volume of 401820.

Niu Technologies’s last close was $7.69, 78.25% below its 52-week high of $35.35.

Niu Technologies’s Revenue

Year-on-year quarterly revenue growth grew by 46.7%, now sitting on 3.7B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Niu Technologies’s stock is considered to be overbought (>=80).

Niu Technologies’s Stock Yearly Top and Bottom Value

Niu Technologies’s stock is valued at $8.75 at 17:32 EST, way under its 52-week high of $35.35 and way higher than its 52-week low of $6.67.

Niu Technologies’s Moving Average

Niu Technologies’s worth is higher than its 50-day moving average of $8.54 and way below its 200-day moving average of $16.32.

More news about Niu Technologies.

5. Coinbase (COIN) – 13.5%

NASDAQ ended the session with Coinbase jumping 13.5% to $58.92 on Thursday, after two sequential sessions in a row of losses. NASDAQ jumped 1.62% to $11,232.19, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for Coinbase is 15070800 which is 28.81% above its average volume of 11699400.

Coinbase’s last close was $51.91, 85.93% below its 52-week high of $368.90.

The company’s growth estimates for the current quarter and the next is a negative 97.7% and a negative 101.2%, respectively.

Coinbase’s Revenue

Year-on-year quarterly revenue growth grew by 327.1%, now sitting on 7.84B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Coinbase’s stock is considered to be oversold (<=20).

Coinbase’s Stock Yearly Top and Bottom Value

Coinbase’s stock is valued at $58.92 at 17:32 EST, way under its 52-week high of $368.90 and way higher than its 52-week low of $40.83.

Coinbase’s Moving Average

Coinbase’s worth is way under its 50-day moving average of $107.90 and way under its 200-day moving average of $210.61.

More news about Coinbase.

6. Wayfair (W) – 12.78%

Wayfair Inc. is an e-commerce company that operates in the United States as well internationally. The company offers approximately 18 million home goods under different brands. It offers a variety of furniture and dA (c)cor products, as well as decorative accents and housewares. Wayfair Inc. was established in 2002. It is located in Boston, Massachusetts.

NYSE ended the session with Wayfair jumping 12.78% to $54.13 on Thursday while NYSE rose 0.34% to $14,402.12.

Volume

Today’s last reported volume for Wayfair is 4008930 which is 3.97% above its average volume of 3855750.

Wayfair’s last close was $48.00, 85.38% below its 52-week high of $328.21.

The company’s growth estimates for the current quarter and the next is a negative 196.8% and a negative 1200%, respectively.

Wayfair’s Revenue

Year-on-year quarterly revenue growth declined by 11.4%, now sitting on 13.71B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Wayfair’s stock is considered to be overbought (>=80).

Wayfair’s Stock Yearly Top and Bottom Value

Wayfair’s stock is valued at $54.13 at 17:32 EST, way under its 52-week high of $328.21 and way higher than its 52-week low of $43.72.

Wayfair’s Moving Average

Wayfair’s value is way below its 50-day moving average of $70.09 and way under its 200-day moving average of $166.23.

More news about Wayfair.

7. Pacific Biosciences of California (PACB) – 12.11%

Pacific Biosciences of California, Inc. develops, manufactures, and markets sequencing systems for complex genetic problems. The single-molecule real time (SMRT), sequencing technology allows for single-molecule detection of biological processes. It also offers consumables such as SMRT cell technology and various reagent kit designs for specific workflows such as template preparation in order to transform DNA into SMRTbell double stranded DNA libraries formats. This includes molecular biology reagents such as ligase buffers exonucleases, buffers, and ligase. It also offers binding kits such as the modified DNA polymerase, which is used to bind SMRTbell library formats to the polymerase, in preparation to sequencing. Sequencing kits include reagents that are required to perform on-instrument real-time sequencing including the phospholinked nouncleotides. It serves commercial labs, genome centers, research institutes, genomics service providers, pharmaceutical companies, and agricultural businesses. The company markets its products via a direct sales force throughout North America and Europe as well as distribution partners across Asia, Europe and the Middle East. Asuragen and Pacific Biosciences have partnered to create assays that can be used for carrier screening, and many other purposes. They use SMRT sequencing technology. In 2005, the company, formerly called Nanofluidics, Inc., was changed to Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc., was established in 2000. It is located in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California rising 12.11% to $5.46 on Thursday, after three successive sessions in a row of gains. NASDAQ jumped 1.62% to $11,232.19, following the last session’s downward trend on what was an all-around up trend exchanging session today.

Volume

Today’s last reported volume for Pacific Biosciences of California is 6061760 which is 15.07% below its average volume of 7137550.

Pacific Biosciences of California’s last close was $4.87, 86.61% under its 52-week high of $36.36.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 17% for the present quarter and 30.3% for the next. The company’s growth estimates for the present quarter and the next is a negative 57.1% and a negative 500%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be oversold (<=20).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.46 at 17:32 EST, way below its 52-week high of $36.36 and way higher than its 52-week low of $4.16.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way below its 50-day moving average of $6.51 and way below its 200-day moving average of $16.44.

More news about Pacific Biosciences of California.

8. Aspen Group (ASPU) – 11.63%

Aspen Group, Inc., a technology-based education company, offers online higher education in the United States. It offers certificates, associate, bachelor, master’s and doctoral degrees in many areas including business, technology and nursing. It had 11444 students who were pursuing degrees as of April 30, 2020. It was established in New York in 1987.

NASDAQ ended the session with Aspen Group rising 11.63% to $0.96 on Thursday while NASDAQ rose 1.62% to $11,232.19.

Volume

Today’s last reported volume for Aspen Group is 43120 which is 52.41% below its average volume of 90625.

Aspen Group’s last close was $0.86, 88.52% below its 52-week high of $7.49.

The company’s growth estimates for the present quarter and the next is a negative 300% and a negative 233.3%, respectively.

Aspen Group’s Revenue

Year-on-year quarterly revenue growth grew by 14%, now sitting on 76.37M for the twelve trailing months.

Aspen Group’s Stock Yearly Top and Bottom Value

Aspen Group’s stock is valued at $0.96 at 17:32 EST, way below its 52-week high of $7.49 and way above its 52-week low of $0.75.

Aspen Group’s Moving Average

Aspen Group’s value is higher than its 50-day moving average of $0.96 and way under its 200-day moving average of $2.66.

More news about Aspen Group.

9. Accuray Incorporated (ARAY) – 11.46%

Accuray Incorporated designs, produces, and markets radiotherapy systems to treat alternative forms of cancer in Asia Pacific, Europe, Asia, Africa, India, Africa and Japan. The CyberKnife System is a robot stereotactic radiosurgery system and stereotactic radiation therapy system that treats various cancers and tumors. It can be used to treat prostate, brain, spine and liver. It also offers the TomoTherapy System and the Radixact System. These integrated radiation therapy systems can be used to treat a variety of types of cancer. It also offers support services such as installation and training after the contract ends. Its products are sold directly to patients, hospitals, and standalone treatment centers through its sales team. Customers can also reach them through group buying organizations and agents in the United States. Accuray Incorporated is located in Sunnyvale in California.

NASDAQ ended the session with Accuray Incorporated rising 11.46% to $2.14 on Thursday, after three successive sessions in a row of gains. NASDAQ rose 1.62% to $11,232.19, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for Accuray Incorporated is 1379760 which is 40.03% above its average volume of 985272.

Accuray Incorporated’s last close was $1.92, 67.62% below its 52-week high of $5.93.

The company’s growth estimates for the ongoing quarter and the next is a negative 500% and a negative 200%, respectively.

Accuray Incorporated’s Revenue

Year-on-year quarterly revenue growth declined by 6.2%, now sitting on 430.82M for the twelve trailing months.

Accuray Incorporated’s Stock Yearly Top and Bottom Value

Accuray Incorporated’s stock is valued at $2.14 at 17:32 EST, way below its 52-week high of $5.93 and way higher than its 52-week low of $1.70.

Accuray Incorporated’s Moving Average

Accuray Incorporated’s worth is way under its 50-day moving average of $2.46 and way under its 200-day moving average of $3.75.

More news about Accuray Incorporated.

10. 10x Genomics (TXG) – 11.45%

10x Genomics, Inc. is a life-science technology company that develops, sells consumables, software, and instruments for analysing biological systems across North America, Europe, Asia Pacific, Africa, China, Middle East, Africa, China, and Asia Pacific. The company sells chromium tools, enzymes and microfluidic chip slides, reagents, as well as other consumables. Its single-cell solution uses its chromium instrument. This includes single-cell gene expression to measure gene activity cell-by-cell; single-cell immune profiling to determine the activity of immune cell targets and epigenetics; single-cell ATAC for measuring epigenetics; single-cell CNV for measuring cell heterogeneity via DNA changes such as copy numbers variation; and single-cell spatial gene expression that maps the patterns of gene expression across tissue samples. The company serves many institutions, including academic, government and biopharmaceutical. 10X Technologies, Inc. was the company’s previous name. In November 2014, it changed its name from 10X Genomics, Inc. 10x Genomics, Inc. is an American company that was established in 2012. Its headquarters are in Pleasanton, California.

NASDAQ ended the session with 10x Genomics jumping 11.45% to $46.49 on Thursday, after five successive sessions in a row of gains. NASDAQ jumped 1.62% to $11,232.19, following the last session’s downward trend on what was an all-around positive trend trading session today.

Volume

Today’s last reported volume for 10x Genomics is 1292100 which is 15.5% below its average volume of 1529270.

10x Genomics’s last close was $41.72, 80.04% below its 52-week high of $208.99.

10x Genomics’s Sales

10x Genomics’s sales growth is 78.1% for the current quarter and 33.2% for the next. The company’s growth estimates for the present quarter and the next is 70.8% and 97.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be oversold (<=20).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $46.49 at 17:33 EST, way under its 52-week low of $128.15.

10x Genomics’s Moving Average

10x Genomics’s worth is way under its 50-day moving average of $155.93 and way under its 200-day moving average of $170.12.

More news about 10x Genomics.

Most Active Losers Today

1. Acorda Therapeutics (ACOR) – -15.32%

Acorda Therapeutics, Inc., is a biopharmaceutical firm that develops and markets therapies for neurological disorders in the United States. Ampyra (dalfampridine), a drug that improves walking for patients suffering from multiple sclerosis, is sold by the company. Inbrija can be used to treat OFF periods of Parkinson’s disease. Fampyra is also sold in Europe and Asia. The company also develops the ARCUS product to treat acute migrain. Phase I of the clinical trial has been completed for the treatment MS. Cimaglerminalfa is for patients with heart failure. Biogen Inc. has a license agreement and collaboration with the company for Ampyra’s development and commercialization. Acorda Therapeutics, Inc., was established in 1995. It is located in Ardsley, New York.

NASDAQ ended the session with Acorda Therapeutics falling 15.32% to $0.52 on Thursday, after two consecutive sessions in a row of losses. NASDAQ jumped 1.62% to $11,232.19, following the last session’s downward trend on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for Acorda Therapeutics is 1773460 which is 7.06% above its average volume of 1656480.

Acorda Therapeutics’s last close was $0.52, 91.82% below its 52-week high of $6.36.

Acorda Therapeutics’s Sales

Acorda Therapeutics’s sales growth is a negative 3.1% for the current quarter and a decline by 9.9% for the next.

Acorda Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 3.1%, now sitting on 129.07M for the twelve trailing months.

Acorda Therapeutics’s Stock Yearly Top and Bottom Value

Acorda Therapeutics’s stock is valued at $0.52 at 17:33 EST, way below its 52-week high of $6.36 and way above its 52-week low of $0.28.

Acorda Therapeutics’s Moving Average

Acorda Therapeutics’s value is way below its 50-day moving average of $0.85 and way under its 200-day moving average of $2.38.

More news about Acorda Therapeutics.

2. Advaxis (ADXS) – -13.77%

Advaxis, Inc. is a biotechnology company at the clinical stage. It focuses on developing and marketing proprietary Listeria monocytogenes technology antigen delivery product in the United States. ADXS-PSA is currently in Phase 2 clinical trial for treatment of metastatic prostate carcinoma; ADXS-503 is in Phase 1/2 clinical studies for treatment of non-small-cell lung cancer; ADXS-504 is for treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. Merck & Co., Inc., OS Therapies, LLC, Aratana Therapeutics Inc., Biocon Limited, Global BioPharma Inc., Knight Therapeutics Inc., and other companies have formed partnerships and collaborations. Advaxis, Inc., was established in Monmouth Junction, New Jersey in 2002.

NASDAQ ended the session with Advaxis dropping 13.77% to $0.06 on Thursday while NASDAQ rose 1.62% to $11,232.19.

Volume

Today’s last reported volume for Advaxis is 1309930 which is 22303.5% above its average volume of 5847.

Advaxis’s last close was $3.40, 94.01% below its 52-week high of $56.80.

Advaxis’s Stock Yearly Top and Bottom Value

Advaxis’s stock is valued at $0.06 at 17:33 EST, below its 52-week low of $0.06.

Advaxis’s Moving Average

Advaxis’s value is way under its 50-day moving average of $5.59 and way below its 200-day moving average of $18.26.

More news about Advaxis.

3. Deutsche Bank (DB) – -11.4%

Deutsche Bank Aktiengesellschaft offers investment and financial services worldwide to individuals and corporate clients. The Corporate Bank section provides services such as cash management, trading finance, lending, trust, agency and securities. Investment Bank offers services for equity advisory and mergers and acquisitions. The segment also offers advisory and fixed income financing. Private Bank provides account and payment services as well as credit and deposit products. It also offers investment advice, digital services and certain digital services. The segment provides wealth management and postal and parcel service. Asset Management provides alternative investment options, such as real estate, infrastructure and private equity; passive investments; insurance and pension solutions; asset liability management; portfolio management solutions; asset allocation advisory; structuring; and overlay to institutions and governments. It had 1,931 branches across Germany as of December 31, 2019. Deutsche Bank Aktiengesellschaft collaborates with Google to develop cloud services. It was established in 1870, and its headquarters are in Frankfurt am Main in Germany.

NYSE ended the session with Deutsche Bank falling 11.4% to $9.06 on Thursday, after two consecutive sessions in a row of losses. NYSE jumped 0.34% to $14,402.12, following the last session’s downward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Deutsche Bank is 12274000 which is 128.6% above its average volume of 5369130.

Deutsche Bank’s last close was $10.22, 33.38% under its 52-week high of $15.34.

The company’s growth estimates for the current quarter is 200% and a drop 76.2% for the next.

Deutsche Bank’s Revenue

Year-on-year quarterly revenue growth grew by 3.5%, now sitting on 24.79B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Deutsche Bank’s stock is considered to be oversold (<=20).

Deutsche Bank’s Stock Yearly Top and Bottom Value

Deutsche Bank’s stock is valued at $9.06 at 17:33 EST, way under its 52-week low of $10.08.

Deutsche Bank’s Moving Average

Deutsche Bank’s worth is way below its 50-day moving average of $12.83 and way under its 200-day moving average of $12.95.

More news about Deutsche Bank.

4. W&T Offshore (WTI) – -10.47%

W&T Offshore, Inc. is an independent producer of natural and oil products. It focuses on the exploration, acquisition, and development of natural and oil properties in the Gulf of Mexico. It sells natural gas liquids and crude oil. The company has a working interest in 41 off-shore fields located in state and federal waters. The company has an interest in leases that cover approximately 669,000 net acres. These are located off the coasts Louisiana, Texas and Mississippi. Houston is the headquarters of this company, which was established in 1983.

NYSE ended the session with W&T Offshore falling 10.47% to $4.96 on Thursday, after four successive sessions in a row of losses. NYSE jumped 0.34% to $14,402.12, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for W&T Offshore is 6422270 which is 30.18% above its average volume of 4933210.

W&T Offshore’s last close was $4.96, 44.95% under its 52-week high of $9.01.

W&T Offshore’s Sales

W&T Offshore’s sales growth is 64.1% for the ongoing quarter and 61.9% for the next.

W&T Offshore’s Revenue

Year-on-year quarterly revenue growth grew by 74%, now sitting on 547.94M for the twelve trailing months.

W&T Offshore’s Stock Yearly Top and Bottom Value

W&T Offshore’s stock is valued at $4.96 at 17:33 EST, way below its 52-week high of $9.01 and way higher than its 52-week low of $2.64.

W&T Offshore’s Moving Average

W&T Offshore’s worth is way under its 50-day moving average of $5.88 and way higher than its 200-day moving average of $4.50.

More news about W&T Offshore.

5. Vermilion Energy (VET) – -8.97%

Vermilion Energy Inc. and its affiliates engage in exploration, development and production of oil and natural gas across North America, Europe and Australia. It has 81% interest in 642,300 acres of land that is under development, 87% interest in 376,000.700 acres of land undeveloped, 613 net-producing natural gas wells, 334 net-producing oil wells (Canada), and 96% interest in 248.900 acres of land. 91% of these acres are undeveloped in Aquitaine or Paris Basins. 325 net oil wells can be found in France and 325 in France. It also has 49% interest in 930,000 acres of net land, 51 net-producing natural gas wells, in the Netherlands, 36,900 acres, 965,900 acres net undeveloped, as well as 61 net-producing oil wells, and eight net-producing natural gas wells, in Germany. It also owns an offshore Corrib natural-gas field, which is located off the coast of Ireland. The Wandoo oil field, with its associated production assets, has a 100% working interest. This field covers approximately 59,600 acres on the Northwest Shelf of Western Australia. The company also owns 138,000 acres in the Powder river basin and 136.6 net-producing oil wells in America; 951,200 acres in Hungary and 244,900 acres in Slovakia. It has 2.4 million acres in Croatia. Vermilion Energy Inc. is located in Calgary, Canada. It was established in 1994.

NYSE ended the session with Vermilion Energy falling 8.97% to $18.57 on Thursday while NYSE rose 0.34% to $14,402.12.

Volume

Today’s last reported volume for Vermilion Energy is 3697530 which is 41.05% above its average volume of 2621380.

Vermilion Energy’s last close was $18.57, 26.92% below its 52-week high of $25.41.

Vermilion Energy’s Sales

Vermilion Energy’s sales growth is 57.7% for the current quarter and 61.8% for the next. The company’s growth estimates for the present quarter is a negative 42.2% and positive 390.3% for the next.

Vermilion Energy’s Revenue

Year-on-year quarterly revenue growth grew by 122.8%, now sitting on 2.3B for the twelve trailing months.

Vermilion Energy’s Stock Yearly Top and Bottom Value

Vermilion Energy’s stock is valued at $18.57 at 17:33 EST, way under its 52-week high of $25.41 and way above its 52-week low of $5.51.

Vermilion Energy’s Moving Average

Vermilion Energy’s value is way under its 50-day moving average of $21.03 and way higher than its 200-day moving average of $15.52.

More news about Vermilion Energy.

6. AGCO (AGCO) – -8.53%

AGCO Corporation is a distributor of agricultural equipment worldwide. AGCO Corporation manufactures and distributes agricultural equipment and related replacement parts worldwide. It has high-powered tractors that can be used for crop cultivation, commercial hay production and soil leveling. It also offers grain storage containers and associated drying and handling equipment systems, seed-processing system and delivery systems for swine or poultry feed; ventilation and watering and equipment for egg production and broiler production. It also offers rectangular and round balers as well as self-propelled windrowers and loader wagons. The company also offers implements such as disc harrows that level seedbeds and add chemicals to the soils. It also provides heavy tillage which breaks up the soil and mixes crop residue with topsoil. Field cultivators are used for preparing smooth seed beds and removing weeds. Drills can be purchased for small-grain seeding. It also offers combine harvesters for corn, wheat and soybeans; as well as application equipment such as self-propelled three- or four-wheeled vehicles and other equipment for liquid fertilizers and crop protection chemicals. Through a network independent distributors and dealers, the company sells its products under Challenger, Fendt and GSI brands. AGCO Corporation was established in 1990. It is located in Duluth in Georgia.

NYSE ended the session with AGCO dropping 8.53% to $97.13 on Thursday, following the last session’s downward trend. NYSE rose 0.34% to $14,402.12, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for AGCO is 914816 which is 18.6% above its average volume of 771320.

AGCO’s last close was $106.19, 29.34% under its 52-week high of $150.28.

AGCO’s Sales

AGCO’s sales growth is 17.9% for the current quarter and 15% for the next. The company’s growth estimates for the present quarter and the next is 1.7% and 27.8%, respectively.

AGCO’s Revenue

Year-on-year quarterly revenue growth grew by 16.1%, now sitting on 11.14B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

AGCO’s stock is considered to be overbought (>=80).

AGCO’s Stock Yearly Top and Bottom Value

AGCO’s stock is valued at $97.13 at 17:33 EST, below its 52-week low of $105.72.

AGCO’s Moving Average

AGCO’s worth is way under its 50-day moving average of $126.76 and way below its 200-day moving average of $125.36.

More news about AGCO.

7. Antero Resources (AR) – -8.53%

Antero Resources Corporation is an independent oil-and-natural gas company that acquires, investigates, develops and produces natural gaz, natural gas liquids and other oil properties throughout the United States. The company owned approximately 451,000 acres of net land in the Marcellus Shale’s southwestern core and 91,000 acres of net land in the Utica Shale core as of December 31, 2019. The company also operated 324 mile of Marcellus Shale gas gathering pipelines, 17 compressor stations and 110 miles of Utica Shale low-pressure/high-pressure gathering pipelines. It also owns and operates 8 miles high-pressure pipelines and two compressor stations. It had proved natural gas reserves estimated at 18.9 trillion cubic yards, which included 11.5 trillion cubic meters of natural gas, 652 million barrels assumed-recovered ethane and 540 million barrels each of normal butane and propane; as well as 42 million barrels oil. Antero Resources Appalachian Corporation was the company’s former name. In June 2013, it changed its name from Antero Resources Corporation to Antero Resources Corporation. Antero Resources Corporation was established in 2002. It is located in Denver, Colorado.

NYSE ended the session with Antero Resources sliding 8.53% to $30.55 on Thursday, following the last session’s downward trend. NYSE jumped 0.34% to $14,402.12, following the last session’s downward trend on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for Antero Resources is 11516700 which is 37.94% above its average volume of 8348880.

The company’s growth estimates for the current quarter and the next is 1007.7% and 689.5%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Antero Resources’s stock is considered to be overbought (>=80).

More news about Antero Resources.

8. Cenovus Energy (CVE) – -8.42%

Cenovus Energy Inc. and its affiliates develop, produce, and market crude oil and natural gas liquids in Canada as well as natural gas products and services throughout the United States. It operates in three segments: Oil Sands, Deep Basin and Refining and Marketing. Oil Sands is responsible for developing and producing bitumen in northeast Alberta. Foster Creek, Christina Lake and Narrows Lake are just a few of its bitumen assets. There is also other early-stage projects. Clearwater, Kaybob-Edson and Elmworth-Wapiti are the main assets of the Deep Basin segment. There is also a variety of interests in natural gas processing plants. Refining and Marketing is responsible for transporting, selling, and refining crude oil to petroleum and other chemical products. The segment holds a half-ownership in Wood River, Borger and other refineries in the United States. It also owns an Alberta crude-by rail terminal. Cenovus Energy Inc. is located in Calgary, Canada. It was established in 2009.

NYSE ended the session with Cenovus Energy sliding 8.42% to $17.77 on Thursday, following the last session’s downward trend. NYSE jumped 0.34% to $14,402.12, following the last session’s downward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Cenovus Energy is 17564700 which is 58.16% above its average volume of 11105100.

Cenovus Energy’s last close was $19.41, 22.08% under its 52-week high of $24.91.

The company’s growth estimates for the ongoing quarter and the next is 744.4% and 300%, respectively.

Cenovus Energy’s Revenue

Year-on-year quarterly revenue growth grew by 74.3%, now sitting on 53.26B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Cenovus Energy’s stock is considered to be oversold (<=20).

Cenovus Energy’s Stock Yearly Top and Bottom Value

Cenovus Energy’s stock is valued at $17.77 at 17:33 EST, way below its 52-week high of $24.91 and way above its 52-week low of $7.20.

Cenovus Energy’s Moving Average

Cenovus Energy’s worth is way below its 50-day moving average of $19.82 and way higher than its 200-day moving average of $14.52.

More news about Cenovus Energy.

9. CNH Industrial (CNHI) – -8.39%

CNH Industrial N.V. produces, markets and sells agricultural and construction equipment. It also designs and manufactures commercial and specialty vehicles and trucks. CNH Industrial N.V.’s Agriculture division offers various farm machinery, such as crawler tractors and tractors with two and four wheels, combines and cotton pickers, grape, sugarcane and wine harvesters, hay, forage and planting equipment. It also sells material handling equipment and soil preparation implements under the New Holland Agriculture and Case IH, STEYR and Miller brands. The Construction segment includes excavators and crawler dozers as well as wheel- and backhoe loaders and compact track and skid steer loaders. Its Commercial and Specialty Vehicles section offers light, medium and heavy vehicles to transport and distribute goods. The company’s Powertrain segment provides engines, transmissions, and axles that can be used on and off-road, in addition to power generation and marine applications under the FPT Industrial name. Financial Services, part of the company, provides financing for customers to purchase and lease new or used industrial equipment, vehicles or other equipment. Wholesale financing, which is primarily floor plans financing, as well as trade receivables and factoring services, are also offered. CNH Industrial N.V. has its headquarters in London, United Kingdom.

NYSE ended the session with CNH Industrial sliding 8.39% to $11.40 on Thursday, after two consecutive sessions in a row of losses. NYSE jumped 0.34% to $14,402.12, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for CNH Industrial is 10167700 which is 134.02% above its average volume of 4344670.

CNH Industrial’s last close was $12.45, 35.22% below its 52-week high of $19.22.

The company’s growth estimates for the present quarter and the next is 118.2% and 13.3%, respectively.

CNH Industrial’s Revenue

Year-on-year quarterly revenue growth grew by 59.8%, now sitting on 31.38B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

CNH Industrial’s stock is considered to be oversold (<=20).

CNH Industrial’s Stock Yearly Top and Bottom Value

CNH Industrial’s stock is valued at $11.40 at 17:34 EST, way under its 52-week high of $19.22 and higher than its 52-week low of $10.95.

CNH Industrial’s Moving Average

CNH Industrial’s worth is way under its 50-day moving average of $17.40 and way under its 200-day moving average of $16.60.

More news about CNH Industrial.

10. Valero Energy (VLO) – -7.63%

Valero Energy Corporation produces and sells transport fuels and other petrochemical products throughout the United States and Canada. The company operates in three main segments, namely Refining and Ethanol. It is engaged in marketing and oil and gas refinement. The company produces premium and conventional gasolines as well as gasoline that meets the requirements of California Air Resources Board (CARB), CARB diesel and low-sulfur/ultra-low-sulfur fuels. It also makes CARB diesel and other distillates, fuels such as jet fuels and asphalts. The company had 15 refineries that could produce approximately 3.15 millions barrels of petroleum per day as of December 31 2019. The company markets refined products via bulk and wholesale markets. It also has approximately 7,000 retail outlets that sell under the Texaco, Valero and Beacon brand names. It also sells corn oil, distiller grains and ethanol to gasoline blenders as well as animal feed customers. The company owns 14 ethanol plants that can produce ethanol at a total annual production of 1.73 billion. The company also owns and operates crude oil, refined petroleum products terminals and other transport and logistics assets. It also owns and runs a facility that converts animal fats, cooking oils and vegetable oils to renewable diesel. The former name of the company was Valero Refining and Marketing Company. In August 1997, it changed its name from Valero Energy Corporation to Valero Energy Corporation. Valero Energy Corporation was established in 1980. It is located in San Antonio Texas.

NYSE ended the session with Valero Energy sliding 7.63% to $104.50 on Thursday, after two sequential sessions in a row of losses. NYSE jumped 0.34% to $14,402.12, following the last session’s downward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Valero Energy is 9362090 which is 77.18% above its average volume of 5283660.

Valero Energy’s last close was $113.13, 33.17% higher than its 52-week high of $84.95.

The company’s growth estimates for the ongoing quarter and the next is 165.5% and 135.8%, respectively.

Valero Energy’s Revenue

Year-on-year quarterly revenue growth grew by 173.9%, now sitting on 75.78B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Valero Energy’s stock is considered to be oversold (<=20).

Valero Energy’s Stock Yearly Top and Bottom Value

Valero Energy’s stock is valued at $104.50 at 17:34 EST, way higher than its 52-week high of $84.95.

Valero Energy’s Moving Average

Valero Energy’s worth is way above its 50-day moving average of $75.38 and way above its 200-day moving average of $73.23.

More news about Valero Energy.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here